Abstract
The obesity epidemic has become a significant issue worldwide. Type 2 diabetes mellitus (T2DM) is related and its prevalence is also on the rise. Bariatric surgery as part of a comprehensive weight management strategy is highly efficacious in treating obese individuals and promoting weight loss. The resultant loss of excess body weight is frequently associated with improvement of comorbid factors such T2DM. This review focuses on both restrictive and malabsorptive bariatric surgical procedures and explores their roles in preventing and treating T2DM. Currently, the use of bariatric surgery as a prevention strategy for T2DM in obese individuals is understudied; however, there is early evidence to suggest a protective effect. In addition, this review summarizes emerging evidence linking bariatric surgery and improvement of T2DM in diabetic obese patients.
Similar content being viewed by others
Reference
Recent publications of particular interest have been highlighted as: • Of importance
DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173–94.
DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161(3):397–405.
WHO. Diabetes: Fact Sheet. 2011;Fact Sheet n. 312.
Public Health Agency of Canada. Report from the National Diabetes Surveillance System: Diabetes in Canada, 2009. 2009; Available at: http://www.phac-aspc.gc.ca/publicat/2009/ndssdic-snsddac-09/2-eng.php. Accessed May 8, 2011.
Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, et al. Diabetes trends in the U.S.: 1990–1998. Diabetes Care. 2000;23(9):1278–83.
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–9.
• Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–67. This study describes the global trends of obesity.
Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32(9):1431–7.
WHO. Obesity and Overweight. 2011;Fact sheet 311.
Tjepkema M. Adult obesity in Canada: measured height and weight. Nutrition: Findings from the Canadian Community Health Survey 2005(1).
Statistics Canada. Canadian health measures survey: adult obesity prevalence in Canada and the United States. 2011; Available at: http://www.statcan.gc.ca/daily-quotidien/110302/dq110302c-eng.htm. Accessed May 10, 2011.
Bonadonna RC, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA. Obesity and insulin resistance in humans: a dose-response study. Metabolism. 1990;39(5):452–9.
Spiegelman D, Israel RG, Bouchard C, Willett WC. Absolute fat mass, percent body fat, and body-fat distribution: which is the real determinant of blood pressure and serum glucose? Am J Clin Nutr. 1992;55(6):1033–44.
Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280(5):E745–51.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.
Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009 Sep;13(41):1-190, 215-357, iii-iv.
Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E, et al. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ. 2007;176(8):S1–S13.
O'Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625–33.
Dixon JB, Strauss BJ, Laurie C, O'Brien PE. Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity (Silver Spring). 2007;15(5):1187–98.
Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.
Bessler M, Daud A, Kim T, DiGiorgi M. Prospective randomized trial of banded versus nonbanded gastric bypass for the super obese: early results. Surg Obes Relat Dis. 2007;3(4):480–4. discussion 484-5.
Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.
Buddeberg-Fischer B, Klaghofer R, Krug L, Buddeberg C, Muller MK, Schoeb O, et al. Physical and psychosocial outcome in morbidly obese patients with and without bariatric surgery: a 4 1/2-year follow-up. Obes Surg. 2006;16(3):321–30.
Stoeckli R, Chanda R, Langer I, Keller U. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res. 2004;12(2):346–50.
• Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256.e5. This meta-analysis highlights the improvement in T2DM following bariatric surgery.
Pontiroli AE, Laneri M, Veronelli A, Frige F, Micheletto G, Folli F, et al. Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol. 2009;8:37.
• Rizzello M, Abbatini F, Casella G, Alessandri G, Fantini A, Leonetti F, et al. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg. 2010;20(1):50–5. This study suggest that changes in insulin resistance may occur early in the postoperative period following sleeve gastrectomy.
Al Harakeh AB, Burkhamer KJ, Kallies KJ, Mathiason MA, Kothari SN. Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery. Surg Obes Relat Dis. 2010;6(6):591–6.
Gill RS, Birch DW, Shi X, Sharma AM, Karmali S. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis. 2010;6(6):707–13.
Lakdawala MA, Bhasker A, Mulchandani D, Goel S, Jain S. Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study. Obes Surg. 2010;6:707–13.
Lirosi F. El Kallaawi M, Batterham RL, Adamo M. Do we need bypass surgery to cure diabetes? Prompt remission of diabetes after laparoscopic sleeve gastrectomy - a UK experience. Surg Obes Relat Dis. 2010;6:229–30.
Shah S, Todkar J, Shah P. Effect of laparoscopic sleeve gastrectomy (LSG) on HbA1c levels in T2DM patients: results after one year. Obes Surg IFSO. 2009;Abstract P-071.
Basso N, Leonetti F, Mariani PP, et al. Early hormonal changes after sleeve gastrectomy in diabetic obese patients. Obes Surg IFSO. 2009;Abstract P-064.
Berry M, Villagran R, Lamoza P, et al. Laparoscopic sleeve gastrectomy (LSG) impact in diabetic (T2DM) obese patients. Obes Surg IFSO. 2009;Abstract P-084.
Chowbey PK, Dhawan K, Khullar R, et al. Laparoscopic sleeve gastrectomy: an Indian experience - surgical technique and early results. Obes Surg Epub 2009.
Jacobs M, Bisland W, Gomez E, et al. Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results. Surg Endosc. 2010;24:781–5.
Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.
Vidal J, Ibarzabal A, Romero F, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008;18:1077–82.
Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75.
• Todkar JS, Shah SS, Shah PS, Gangwani J. Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6(2):142–5. This study describes the long-term weight loss and improvement in T2DM following sleeve gastrectomy.
Trostler N, Mann A, Zilberbush N, Avinoach E, Charuzi II. Weight Loss and Food Intake 18 Months following Vertical Banded Gastroplasty or Gastric Bypass for Severe Obesity. Obes Surg. 1995;5(1):39–51.
Halmi KA, Mason E, Falk JR, Stunkard A. Appetitive behavior after gastric bypass for obesity. Int J Obes. 1981;5(5):457–64.
Pournaras DJ, Osborne A, Hawkins SC, Vincent RP, Mahon D, Ewings P, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 2010;252(6):966–71.
Cummings DE, Overduin J, Shannon MH, Foster-Schubert KE. 2004 ABS Consensus Conference. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery Surg Obes Relat Dis. 2005;1(3):358–68.
Drucker DJ. Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology. 2003;144(12):5145–8.
Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84. discussion 84-5.
Pories WJ. Diabetes: the evolution of a new paradigm. Ann Surg. 2004;239(1):12–3.
Cummings DE, Shannon MH. Roles for ghrelin in the regulation of appetite and body weight. Arch Surg. 2003;138(4):389–96.
Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab. 2001;86(10):5083–6.
Disclosure
No conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gill, R.S., Whitlock, K., Sandhu, R.K. et al. Bariatric Surgery to Prevent and Treat Diabetes. Curr Cardiovasc Risk Rep 6, 135–140 (2012). https://doi.org/10.1007/s12170-011-0218-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12170-011-0218-9